0 CHECKOUT

Serbia Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3517935
  • December 2015
  • Region: Serbia
  • 88 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Krka
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

The Serbian pharmaceutical and healthcare market represents a challenging environment for foreign drugmakers. Government cost containment, implemented through severe drug price cuts by the RFZO, will dampen growth. Furthermore, an increasing reliance on private health spending will impact pharmaceutical sales as the worsening macroeconomic outlook will reduce consumer spending power.

Headline Expenditure Projections Pharmaceuticals: RSD92.43bn (USD1.05bn) in 2014 to RSD91.42bn (USD820mn) in 2015; -1.1% in local currency terms and -21.5% in US dollar terms. Forecast unchanged from Q415.

Healthcare: RSD389.48bn (USD4.40bn) in 2014 to RSD384.91bn (USD3.45bn) in 2015; -1.2% in local currency terms and -21.6% in US dollar terms. Forecasts unchanged from Q415.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Krka
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Serbia 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Serbia 2013-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2013-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2013-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2013-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Serbia 2013-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Serbia 2013-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Serbia 2013-2019)

OTC Medicines Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Serbia 2013-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Serbia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Serbia 2013-2019)

Pharmaceuticals & Healthcare Risk/Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Serbia Risk/Reward Index

Rewards

Risks

Regulatory Review

Registration Renewals

Intellectual Property Environment

Promotion

Pricing Regime

Reimbursement Regime

Market Overview

Epidemiology
Table: Serbian Cancer Incidence Rates, 2012-2035

Healthcare Sector

Healthcare Insurance
Table: Healthcare Resources (Serbia 2009-2014)
Table: Healthcare Personnel (Serbia 2009-2014)
Table: Healthcare Activity (Serbia 2009-2014)

Research & Development

Clinical Trials

Competitive Landscape

Research-Based Industry

Generic Drugmakers

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

GlaxoSmithKline

Krka

Merck

Novartis

Pfizer

Sanofi

Zdravlje Actavis

Demographic Forecast
Table: Population Headline Indicators (Serbia 2005-2025)
Table: Population By Age Group (Serbia 2005-2025)
Table: Population By Age Group % (Serbia 2005-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

GlaxoSmithKline
Krka
Merck
Novartis
Pfizer
Sanofi
Zdravlje Actavis

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.